glp-1 type 2 diabetes Clinical Focus on Agonists in Mellitus Can Type 1 and Type
Description
New item
Remedy Meds Review is a telemedicine evaluation platform connecting patients to GLP-1 providers
Latest review of the Tirzepatide dual receptor agonist GLP-1/GIP, summarizing five clinical trials in type 2-diabetic subjects.
Amgen is taking their own approach to weight loss with their investigational obesity drug #MariTide
